Sfoglia per Autore
Computational tools in the discovery of FABP4 ligands: A statistical and molecular modeling approach
2019-01-01 Floresta, G.; Gentile, D.; Perrini, G.; Patamia, Vincenzo; Rescifina, A.
Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach†
2020-01-01 Floresta, G.; Patamia, V.; Gentile, D.; Molteni, F.; Santamato, A.; Rescifina, A.; Vecchio, M.
Putative inhibitors of SARS-COV-2 main protease from a library of marine natural products: A virtual screening and molecular modeling study
2020-01-01 Gentile, D.; Patamia, V.; Scala, A.; Sciortino, M. T.; Piperno, A.; Rescifina, A.
An integrated pharmacophore/docking/3D-QSAR approach to screening a large library of products in search of future botulinum neurotoxin a inhibitors
2020-01-01 Gentile, D.; Floresta, G.; Patamia, V.; Chiaramonte, R.; Mauro, G. L.; Rescifina, A.; Vecchio, M.
Cucurbit[7]uril as a catalytic nanoreactor for one-pot synthesis of isoxazolidines in water
2020-01-01 Gentile, Davide; Floresta, Giuseppe; Patamia, Vincenzo; Nicosia, Angelo; Mineo, Placido; Rescifina, Antonio
Nanosponges based on self-assembled starfish-shaped cucurbit[6]urils functionalized with imidazolium arms
2021-01-01 Patamia, Vincenzo; Gentile, Davide; Fiorenza, Roberto; Muccilli, Vera; Mineo, Placido G.; Scirè, Salvatore; Rescifina, Antonio
From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes
2021-01-01 Floresta, G.; Fallica, A. N.; Patamia, V.; Sorrenti, V.; Greish, K.; Rescifina, A.; Pittala, V.
Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects
2021-01-01 Gentile, Davide; Patamia, Vincenzo; Fuochi, Virginia; Furneri, Pio M; Rescifina, Antonio
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design
2022-01-01 Floresta, G.; Zagni, C.; Gentile, D.; Patamia, V.; Rescifina, A.
Green efficient one‐pot synthesis and separation of nitrones in water assisted by a self‐assembled nanoreactor
2022-01-01 Patamia, V.; Floresta, G.; Pistara, V.; Rescifina, A.
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties
2022-01-01 Szczepańska, Katarzyna; Podlewska, Sabina; Dichiara, Maria; Gentile, Davide; Patamia, Vincenzo; Rosier, Niklas; Mönnich, Denise; Ruiz Cantero M., Carmen; Karcz, Tadeusz; Łażewska, Dorota; Siwek, Agata; Pockes, Steffen; Cobos J., Enrique; Marrazzo, Agostino; Stark, Holger; Rescifina, Antonio; Bojarski J., Andrzej; Amata, Emanuele; Kieć-Kononowicz, Katarkyna
Synthesis, in vitro evaluation, and molecular modeling studies of LP2 analogs
2022-01-01 Costanzo, Giuliana; Patamia, Vincenzo; Amata, Emanuele; Rescifina, Antonio; Lorella Pasquinucci, And
Novel Class of Proteasome Inhibitors: In Silico and In Vitro Evaluation of Diverse Chloro(trifluoromethyl)aziridines
2022-01-01 Ielo, L.; Patamia, V.; Citarella, A.; Efferth, T.; Shahhamzehei, N.; Schirmeister, T.; Stagno, C.; Langer, T.; Rescifina, A.; Micale, N.; Pace, V.
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022
2022-01-01 Floresta, G.; Patamia, V.; Zagni, C.; Rescifina, A.
A sustainable porous composite material based on loofah-halloysite for gas adsorption and drug delivery
2022-01-01 Patamia, Vincenzo; Fiorenza, Roberto; Brullo, Ilaria; Zambito Marsala, Massimo; Balsamo, Stefano Andrea; Distefano, Alfio; Furneri, Pio Maria; Barbera, Vincenzina; Scire, Salvatore; Rescifina, Antonio
Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process
2022-01-01 Gentile, D.; Coco, A.; Patamia, V.; Zagni, C.; Floresta, G.; Rescifina, A.
Cucurbiturils, tetrahedral capsules, and porous systems: synthesis, functionalization, and applications
2022-03-29 Patamia, Vincenzo
NOVEL N-NORMETAZOCINE DERIVATIVES WITH SIGMA-1 RECEPTOR ANTAGONIST PROFILE AS POTENTIAL ANALGESICS FOR INFLAMMATORY PAIN MANAGEMENT
file da validare2023-01-01 Costanzo, G.; Cosentino, G.; Patamia, V.; Turnaturi, R.; Parenti, C.; Rescifina, A.; Marrazzo, A.; Amata, E; Pasquinucci, L.
Selective noncovalent proteasome inhibiting activity of trifluoromethyl-containing gem-quaternary aziridines
2023-01-01 Ielo, Laura; Patamia, Vincenzo; Citarella, Andrea; Schirmeister, Tanja; Stagno, Claudio; Rescifina, Antonio; Micale, Nicola; Pace, Vittorio
Total Bio-Based Material for Drug Delivery and Iron Chelation to Fight Cancer through Antimicrobial Activity
2023-01-01 Patamia, Vincenzo; Zagni, Chiara; Fiorenza, Roberto; Fuochi, Virginia; Dattilo, Sandro; Riccobene, Paolo Maria; Furneri, Pio Maria; Floresta, Giuseppe; Rescifina, Antonio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Computational tools in the discovery of FABP4 ligands: A statistical and molecular modeling approach | 1-gen-2019 | Floresta, G.; Gentile, D.; Perrini, G.; Patamia, Vincenzo; Rescifina, A. | |
| Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach† | 1-gen-2020 | Floresta, G.; Patamia, V.; Gentile, D.; Molteni, F.; Santamato, A.; Rescifina, A.; Vecchio, M. | |
| Putative inhibitors of SARS-COV-2 main protease from a library of marine natural products: A virtual screening and molecular modeling study | 1-gen-2020 | Gentile, D.; Patamia, V.; Scala, A.; Sciortino, M. T.; Piperno, A.; Rescifina, A. | |
| An integrated pharmacophore/docking/3D-QSAR approach to screening a large library of products in search of future botulinum neurotoxin a inhibitors | 1-gen-2020 | Gentile, D.; Floresta, G.; Patamia, V.; Chiaramonte, R.; Mauro, G. L.; Rescifina, A.; Vecchio, M. | |
| Cucurbit[7]uril as a catalytic nanoreactor for one-pot synthesis of isoxazolidines in water | 1-gen-2020 | Gentile, Davide; Floresta, Giuseppe; Patamia, Vincenzo; Nicosia, Angelo; Mineo, Placido; Rescifina, Antonio | |
| Nanosponges based on self-assembled starfish-shaped cucurbit[6]urils functionalized with imidazolium arms | 1-gen-2021 | Patamia, Vincenzo; Gentile, Davide; Fiorenza, Roberto; Muccilli, Vera; Mineo, Placido G.; Scirè, Salvatore; Rescifina, Antonio | |
| From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes | 1-gen-2021 | Floresta, G.; Fallica, A. N.; Patamia, V.; Sorrenti, V.; Greish, K.; Rescifina, A.; Pittala, V. | |
| Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects | 1-gen-2021 | Gentile, Davide; Patamia, Vincenzo; Fuochi, Virginia; Furneri, Pio M; Rescifina, Antonio | |
| Artificial Intelligence Technologies for COVID-19 De Novo Drug Design | 1-gen-2022 | Floresta, G.; Zagni, C.; Gentile, D.; Patamia, V.; Rescifina, A. | |
| Green efficient one‐pot synthesis and separation of nitrones in water assisted by a self‐assembled nanoreactor | 1-gen-2022 | Patamia, V.; Floresta, G.; Pistara, V.; Rescifina, A. | |
| Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties | 1-gen-2022 | Szczepańska, Katarzyna; Podlewska, Sabina; Dichiara, Maria; Gentile, Davide; Patamia, Vincenzo; Rosier, Niklas; Mönnich, Denise; Ruiz Cantero M., Carmen; Karcz, Tadeusz; Łażewska, Dorota; Siwek, Agata; Pockes, Steffen; Cobos J., Enrique; Marrazzo, Agostino; Stark, Holger; Rescifina, Antonio; Bojarski J., Andrzej; Amata, Emanuele; Kieć-Kononowicz, Katarkyna | |
| Synthesis, in vitro evaluation, and molecular modeling studies of LP2 analogs | 1-gen-2022 | Costanzo, Giuliana; Patamia, Vincenzo; Amata, Emanuele; Rescifina, Antonio; Lorella Pasquinucci, And | |
| Novel Class of Proteasome Inhibitors: In Silico and In Vitro Evaluation of Diverse Chloro(trifluoromethyl)aziridines | 1-gen-2022 | Ielo, L.; Patamia, V.; Citarella, A.; Efferth, T.; Shahhamzehei, N.; Schirmeister, T.; Stagno, C.; Langer, T.; Rescifina, A.; Micale, N.; Pace, V. | |
| Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022 | 1-gen-2022 | Floresta, G.; Patamia, V.; Zagni, C.; Rescifina, A. | |
| A sustainable porous composite material based on loofah-halloysite for gas adsorption and drug delivery | 1-gen-2022 | Patamia, Vincenzo; Fiorenza, Roberto; Brullo, Ilaria; Zambito Marsala, Massimo; Balsamo, Stefano Andrea; Distefano, Alfio; Furneri, Pio Maria; Barbera, Vincenzina; Scire, Salvatore; Rescifina, Antonio | |
| Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process | 1-gen-2022 | Gentile, D.; Coco, A.; Patamia, V.; Zagni, C.; Floresta, G.; Rescifina, A. | |
| Cucurbiturils, tetrahedral capsules, and porous systems: synthesis, functionalization, and applications | 29-mar-2022 | Patamia, Vincenzo | |
| NOVEL N-NORMETAZOCINE DERIVATIVES WITH SIGMA-1 RECEPTOR ANTAGONIST PROFILE AS POTENTIAL ANALGESICS FOR INFLAMMATORY PAIN MANAGEMENT | 1-gen-2023 | Costanzo, G.; Cosentino, G.; Patamia, V.; Turnaturi, R.; Parenti, C.; Rescifina, A.; Marrazzo, A.; Amata, E; Pasquinucci, L. | file da validare |
| Selective noncovalent proteasome inhibiting activity of trifluoromethyl-containing gem-quaternary aziridines | 1-gen-2023 | Ielo, Laura; Patamia, Vincenzo; Citarella, Andrea; Schirmeister, Tanja; Stagno, Claudio; Rescifina, Antonio; Micale, Nicola; Pace, Vittorio | |
| Total Bio-Based Material for Drug Delivery and Iron Chelation to Fight Cancer through Antimicrobial Activity | 1-gen-2023 | Patamia, Vincenzo; Zagni, Chiara; Fiorenza, Roberto; Fuochi, Virginia; Dattilo, Sandro; Riccobene, Paolo Maria; Furneri, Pio Maria; Floresta, Giuseppe; Rescifina, Antonio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile